Insider · CIK 0001542768

Cantor Maria E

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001542768

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-26	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	SVP, Investor Rel. & Comm.	AAward	+19.2K sh	—	—	19,169
2018-01-26	QUREuniQure N.V.A Award	SVP, Investor Rel. & Comm.	AAward	+7,188 sh	—	—	92,439
2018-01-03	QUREuniQure N.V.S Sale	SVP, Investor Rel. & Comm.	SSale	−5,864 sh	$20.13	−$118K	85,251
2017-12-13	QUREuniQure N.V.A Award	SVP, Investor Rel. & Comm.	AAward	+56.1K sh	—	—	56,115
2017-01-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	SVP, Investor Rel. & Comm.	AAward	+43K sh	—	—	43,000
2017-01-27	QUREuniQure N.V. · Preformance Share UnitA Award	SVP, Investor Rel. & Comm.	AAward	+43.5K sh	—	—	43,500
2017-01-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	SVP, Investor Rel. & Comm.	AAward	+43.3K sh	—	—	43,250
2017-01-27	QUREuniQure N.V. · Preformance Share UnitA Award	SVP, Investor Rel. & Comm.	AAward	+43.3K sh	—	—	43,250
2016-04-29	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+13.3K sh	—	—	149,001
2016-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−13.3K sh	—	—	0
2016-04-29	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP, Corporate Affairs	FTax Payment	−4,334 sh	$7.18	−$31.1K	144,667
2016-03-19	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−3,575 sh	$6.46	−$23.1K	135,667
2016-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+6,500 sh	—	—	139,242
2016-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−6,500 sh	—	—	0
2016-03-07	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Corporate Affairs	AAward	+15.3K sh	—	—	15,300
2016-03-07	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	SVP, Corporate Affairs	AAward	+51K sh	$6.51	+$332K	51,000
2016-03-03	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−9,625 sh	$6.12	−$58.9K	132,742
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP, Corporate Affairs	AAward	+38.5K sh	—	—	38,500
2016-03-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+19.3K sh	—	—	142,367
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−19.3K sh	—	—	19,250
2016-02-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+29.3K sh	—	—	139,250
2016-02-01	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−14.7K sh	$4.81	−$70.5K	123,117
2016-02-01	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−1,466 sh	$4.93	−$7,227.38	137,784
2016-02-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−29.3K sh	—	—	29,333
2015-09-28	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−5,000 sh	$6.47	−$32.3K	109,917
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP, Corporate Affairs	AAward	+20K sh	—	—	20,000
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−10K sh	—	—	10,000
2015-09-24	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+10K sh	—	—	114,917
2015-09-01	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−2,696 sh	$9.11	−$24.6K	104,917
2015-08-28	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−1,268 sh	$10.00	−$12.7K	107,613
2015-07-16	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−4,000 sh	$8.54	−$34.2K	108,881
2015-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−8,000 sh	—	—	0
2015-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+8,000 sh	—	—	112,881
2015-04-30	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Corporate Affairs	AAward	+40K sh	—	—	40,000
2015-03-23	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−4,033 sh	$8.55	−$34.5K	104,881
2015-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−7,333 sh	—	—	0
2015-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+7,333 sh	—	—	108,916
2015-03-20	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−3,575 sh	$8.85	−$31.6K	101,583
2015-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−6,500 sh	—	—	6,500
2015-03-19	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−7,875 sh	—	—	23,625
2015-03-19	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−1,471 sh	$9.00	−$13.2K	105,158
2015-03-19	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−7,875 sh	$9.00	−$70.9K	106,629
2015-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+7,875 sh	$3.08	+$24.3K	114,504
2015-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+6,500 sh	—	—	106,629
2015-02-02	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	−29.3K sh	—	—	58,666
2015-02-02	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−16.1K sh	$6.33	−$102K	100,129
2015-02-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+29.3K sh	—	—	116,263
2014-11-24	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−1,749 sh	$7.00	−$12.2K	86,929
2014-09-02	ARIAD PHARMACEUTICALS INCS Sale	SVP, Corporate Affairs	SSale	−2,696 sh	$6.21	−$16.8K	88,678
2014-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Corporate Affairs	MExercise/Conversion	+8,000 sh	—	—	93,982

Recent filings

Accepted (ET)
Jan 304
Cantor Maria E0000904454-18-000068
SEC(opens sec.gov)
Jan 34
Cantor Maria E0001209191-18-001197
SEC(opens sec.gov)
Dec 154
Cantor Maria E0001209191-17-065943
SEC(opens sec.gov)
Feb 214/A
uniQure N.V.0001140361-17-008374
SEC(opens sec.gov)
Jan 314
uniQure N.V.0001140361-17-003720
SEC(opens sec.gov)
May 24
ARIAD PHARMACEUTICALS INC0000884731-16-000042
SEC(opens sec.gov)
Mar 224
ARIAD PHARMACEUTICALS INC0000884731-16-000022
SEC(opens sec.gov)
Mar 94
ARIAD PHARMACEUTICALS INC0001628280-16-012504
SEC(opens sec.gov)
Mar 34
ARIAD PHARMACEUTICALS INC0001127602-16-044959
SEC(opens sec.gov)

Companies

Address

C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139